skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Uses of monoclonal antibody 8H9

Abstract

This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof.

Inventors:
Issue Date:
Research Org.:
Sloan-Kettering Institute For Cancer Research, New York, NY (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1176364
Patent Number(s):
7,737,258
Application Number:
10/097,558
Assignee:
Sloan-Kettering Institute For Cancer Research (New York, NY)
DOE Contract Number:  
FG02-93ER61658
Resource Type:
Patent
Resource Relation:
Patent File Date: 2002 Mar 08
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 60 APPLIED LIFE SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY

Citation Formats

Cheung, Nai-Kong V. Uses of monoclonal antibody 8H9. United States: N. p., 2010. Web.
Cheung, Nai-Kong V. Uses of monoclonal antibody 8H9. United States.
Cheung, Nai-Kong V. Tue . "Uses of monoclonal antibody 8H9". United States. https://www.osti.gov/servlets/purl/1176364.
@article{osti_1176364,
title = {Uses of monoclonal antibody 8H9},
author = {Cheung, Nai-Kong V.},
abstractNote = {This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2010},
month = {6}
}

Patent:

Save / Share:

Works referenced in this record:

Secretion of a single-gene-encoded immunoglobulin from myeloma cells.
journal, September 1993

  • Shu, L.; Qi, C. F.; Schlom, J.
  • Proceedings of the National Academy of Sciences, Vol. 90, Issue 17
  • DOI: 10.1073/pnas.90.17.7995

Novel tumor target for antibody-based therapy of rhabdomyosarcoma and other pediatric solid tumors
journal, January 2000


Surface Antigen Expression and Complement Susceptibility of Differentiated Neuroblastoma Clones
journal, March 2000

  • Chen, Shaohua; Caragine, Theresa; Cheung, Nai-Kong V.
  • The American Journal of Pathology, Vol. 156, Issue 3, p. 1085-1091
  • DOI: 10.1016/S0002-9440(10)64976-0

SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2
journal, January 1994

  • De Leij, Lou; Helrich, Wijnand; Stein, Rhona
  • International Journal of Cancer, Vol. 57, Issue S8
  • DOI: 10.1002/ijc.2910570713

Improved Gene Transfer into Human Lymphocytes Using Retroviruses with the Gibbon Ape Leukemia Virus Envelope
journal, August 1996


Desmoplastic Small Round Cell Tumor: II: An Ultrastructural and Immunohistochemical Study with Emphasis on New Immunohistochemical Markers
journal, January 1998


Gamma Camera Dual Imaging with a Somatostatin Receptor and Thymidine Kinase after Gene Transfer with a Bicistronic Adenovirus in Mice
journal, May 2002


Complete Tumor Ablation With Iodine 131-Radiolabeled Disialoganglioside GD2-Specific Monoclonal Antibody Against Human Neuroblastoma Xenografted in Nude Mice23
journal, September 1986

  • Cheung, Nai-Kong V.; Landmeier, Bonnie; Neely, John
  • JNCI: Journal of the National Cancer Institute, Vol. 77, Issue 3
  • DOI: 10.1093/jnci/77.3.739

Autologous stem cell transplantation for solid tumors in children
journal, January 1997


Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas
journal, December 1998

  • Kishima, H.; Shimizu, K.; Tamura, K.
  • British Journal of Cancer, Vol. 79, Issue 2
  • DOI: 10.1038/sj.bjc.6690053

Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells
journal, July 1997

  • Ghetie, M. -A.; Podar, E. M.; Ilgen, A.
  • Proceedings of the National Academy of Sciences, Vol. 94, Issue 14
  • DOI: 10.1073/pnas.94.14.7509

Expression of Somatostatin Receptor Subtype 2 mRNA in Human Lymphoid Cells
journal, October 1997

  • Tsutsumi, Akito; Takano, Hina; Ichikawa, Kenji
  • Cellular Immunology, Vol. 181, Issue 1
  • DOI: 10.1006/cimm.1997.1193

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
journal, September 1979

  • Towbin, H.; Staehelin, T.; Gordon, J.
  • Proceedings of the National Academy of Sciences, Vol. 76, Issue 9, p. 4350-4354
  • DOI: 10.1073/pnas.76.9.4350

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
journal, September 1998


Rapid selection of antigen-specific T lymphocytes by retroviral transduction
journal, July 2000


Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood
journal, January 1994


Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy
journal, July 1997

  • Furhang, E. E.; Chui, C. S.; Kolbert, K. S.
  • Medical Physics, Vol. 24, Issue 7
  • DOI: 10.1118/1.598018

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

  • Köhler, G.; Milstein, C.
  • Nature, Vol. 256, Issue 5517, p. 495-497
  • DOI: 10.1038/256495a0

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.
journal, May 1996


A Monte Carlo approach to patient-specific dosimetry
journal, September 1996

  • Furhang, Eli E.; Chui, Chen-Shou; Sgouros, George
  • Medical Physics, Vol. 23, Issue 9
  • DOI: 10.1118/1.597882

Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.
journal, May 1994

  • Moritz, D.; Wels, W.; Mattern, J.
  • Proceedings of the National Academy of Sciences, Vol. 91, Issue 10
  • DOI: 10.1073/pnas.91.10.4318

Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene
journal, August 1994


Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?
journal, January 1984

  • Koprowski, H.; Herlyn, D.; Lubeck, M.
  • Proceedings of the National Academy of Sciences, Vol. 81, Issue 1
  • DOI: 10.1073/pnas.81.1.216

High-Efficiency Gene Transfer into Normal and Adenosine Deaminase-Deficient T Lymphocytes Is Mediated by Transduction on Recombinant Fibronectin Fragments
journal, January 1998


Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.
journal, February 1989


Impact of chimeric immune receptor extracellular protein domains on T cell function
journal, March 1999


Tyrosine kinase chimeras for antigen-selective T-body therapy
journal, April 1998


Barriers to Drug Delivery in Solid Tumors
journal, July 1994


Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues
journal, September 2000


Detection of Prostatic Specific Membrane Antigen Messenger RNA Using Immunobead Reverse Transcriptase Polymerase Chain Reaction
journal, January 1999


Hexabrachion Protein (Tenascin, Cytotactin, Brachionectin) in Connective Tissues, Embryonic Brain, and Tumors
journal, January 1988


In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
journal, June 1992


The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y
journal, June 1991


Common Musculoskeletal Tumors of Childhood and Adolescence
journal, July 1999


Radioimmunotherapy with alpha-emitting nuclides
journal, September 1998

  • McDevitt, Michael R.; Sgouros, George; Finn, Ronald D.
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 25, Issue 9
  • DOI: 10.1007/s002590050306

Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.
journal, January 1994


Rhabdomyosarcoma
journal, August 1997

  • Pappo, Alberto S.; Shapiro, David N.; Crist, William M.
  • Pediatric Clinics of North America, Vol. 44, Issue 4
  • DOI: 10.1016/S0031-3955(05)70539-3

Rapid Death of Adoptively Transferred T Cells in Acquired Immunodeficiency Syndrome
journal, March 1999


3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
journal, June 1998


Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor
journal, July 1990


Detection of (11; 22)(q24;q12) Translocation-Bearing Cells in Peripheral Blood Progenitor Cells of Patients With Ewing's Sarcoma Family of Tumors
journal, March 1995

  • Toretsky, J. A.; Neckers, L.; Wexler, L. H.
  • JNCI Journal of the National Cancer Institute, Vol. 87, Issue 5
  • DOI: 10.1093/jnci/87.5.385

Extended-cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantation
journal, July 1993


Mammalian expression of single chain variable region fragments dimerized by Fc regions
journal, January 1995

  • Kato, Tomohiro; Sato, Keiko; Suzuki, Satoshi
  • Molecular Biology Reports, Vol. 21, Issue 3
  • DOI: 10.1007/BF00997236

Single‐chain Fvs
journal, January 1995


Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation
journal, April 1994

  • Papadopoulos, Esperanza B.; Ladanyi, Marc; Emanuel, David
  • New England Journal of Medicine, Vol. 330, Issue 17
  • DOI: 10.1056/NEJM199404283301703

The Diagnostic Utility of Desmin: A Study of 584 Cases and Review of the Literature
journal, March 1990

  • Truong, Luan D.; Rangdaeng, Samreung; Cagle, Philip
  • American Journal of Clinical Pathology, Vol. 93, Issue 3
  • DOI: 10.1093/ajcp/93.3.305

Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas
journal, November 1993

  • Moriuchi, S.; Shimizu, K.; Miyao, Y.
  • British Journal of Cancer, Vol. 68, Issue 5
  • DOI: 10.1038/bjc.1993.441

Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients
journal, January 1995

  • Uttenreuther-Fischer, Martina M.; Huang, Chuin-Sheng; Reisfeld, Ralph A.
  • Cancer Immunology Immunotherapy, Vol. 41, Issue 1
  • DOI: 10.1007/BF01788957

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
journal, October 1995

  • Walter, Elizabeth A.; Greenberg, Philip D.; Gilbert, Mark J.
  • New England Journal of Medicine, Vol. 333, Issue 16
  • DOI: 10.1056/NEJM199510193331603

Role of High-Dose Chemotherapy With Hematopoietic Stem Cell Rescue in the Treatment of Metastatic or Recurrent Rhabdomyosarcoma
journal, January 2001


Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
journal, March 2003

  • Koehne, Guenther; Doubrovin, Mikhail; Doubrovina, Ekaterina
  • Nature Biotechnology, Vol. 21, Issue 4
  • DOI: 10.1038/nbt805

Specific Lysis of Melanoma Cells by Receptor Grafted T Cells is Enhanced by Anti-Idiotypic Monoclonal Antibodies Directed to the scFv Domain of the Receptor
journal, May 1999


Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.
journal, October 1993


Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma
journal, March 1992

  • Saleh, Mansoor N.; Khazaeli, M. B.; Wheeler, Richard H.
  • Human Antibodies, Vol. 3, Issue 1
  • DOI: 10.3233/HAB-1992-3104

Anti-Tumor Activity of Human T Cells Expressing the CC49-zeta Chimeric Immune Receptor
journal, January 1999


CANCER MODELS: Systems for Identifying New Drugs Are Often Faulty
journal, November 1997


Anti-Idiotypic Antibody as the Surrogate Antigen for Cloning scFv and its Fusion Proteins
journal, December 2002


Single-chain antigen-binding proteins
journal, October 1988


A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
journal, April 1987

  • Rosenberg, Steven A.; Lotze, Michael T.; Muul, Linda M.
  • New England Journal of Medicine, Vol. 316, Issue 15
  • DOI: 10.1056/NEJM198704093161501

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
journal, June 1998


Human Glioma-Specific Antigens Detected by Monoclonal Antibodies
journal, January 1992


Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
journal, February 1997


Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes
journal, May 2004

  • Baxevanis, ConstantinN.; Papamichail, Michael
  • Cancer Immunology, Immunotherapy, Vol. 53, Issue 10
  • DOI: 10.1007/s00262-004-0523-y

Single-chain antibody streptavidin fusions: Tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen
journal, September 1995

  • Kipriyanov, Sergey M.; Breitling, Frank; Little, Melvyn
  • Human Antibodies, Vol. 6, Issue 3
  • DOI: 10.3233/HAB-1995-6303

Expression of single-chain Fv-Fc fusions in Pichia pastoris
journal, May 2001

  • Powers, David B.; Amersdorfer, Peter; Poul, Marie-Alix
  • Journal of Immunological Methods, Vol. 251, Issue 1-2
  • DOI: 10.1016/S0022-1759(00)00290-8

Disialoganglioside GD2 and a novel tumor antigen: Potential targets for immunotherapy of desmoplastic small round cell tumor
journal, October 2002

  • Modak, Shakeel; Gerald, William; Cheung, Nai-Kong V.
  • Medical and Pediatric Oncology, Vol. 39, Issue 6
  • DOI: 10.1002/mpo.10151

Clinical Applications of CD34 + Peripheral Blood Progenitor Cells (PBPC)
journal, March 2000


Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy
journal, January 1999

  • Czuczman, M. S.; Grillo-López, A. J.; White, C. A.
  • Journal of Clinical Oncology, Vol. 17, Issue 1
  • DOI: 10.1200/JCO.1999.17.1.268

Autologous stem cell transplantation for high-risk pediatric solid tumors
journal, September 1999

  • Perentesis, Jp; Katsanis, E.; DeFor, Te
  • Bone Marrow Transplantation, Vol. 24, Issue 6
  • DOI: 10.1038/sj.bmt.1701950

An optimized method for cell-based phage display panning
journal, March 1997


Efficient Discrimination between Different Densities of Target Antigen by Tetracycline-Regulatable T Bodies
journal, March 1999


Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92
journal, June 2001

  • Maki, Guitta; Klingemann, Hans-G.; Martinson, Jeffrey A.
  • Journal of Hematotherapy & Stem Cell Research, Vol. 10, Issue 3
  • DOI: 10.1089/152581601750288975

A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice.
journal, September 1994

  • Sabzevari, H.; Gillies, S. D.; Mueller, B. M.
  • Proceedings of the National Academy of Sciences, Vol. 91, Issue 20
  • DOI: 10.1073/pnas.91.20.9626

Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
journal, February 1996

  • Grant, Stefan C.; Kostakoglu, Lale; Kris, Mark G.
  • European Journal of Nuclear Medicine, Vol. 23, Issue 2
  • DOI: 10.1007/BF01731837

Radionuclide photon dose kernels for internal emitter dosimetry
journal, May 1996

  • Furhang, Eli E.; Sgouros, George; Chui, Chen-Shou
  • Medical Physics, Vol. 23, Issue 5
  • DOI: 10.1118/1.597670

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma
journal, January 1995


A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody.
journal, July 1986

  • Thanavala, Y. M.; Brown, S. E.; Howard, C. R.
  • The Journal of Experimental Medicine, Vol. 164, Issue 1
  • DOI: 10.1084/jem.164.1.227

Multimodality Diagnostics and Megatherapy in Poor Prognosis Ewing's Tumor Patients
journal, October 1999

  • Laws, Hans-Jürgen; Burdach, Stefan; van Kaik, Birgitt
  • Strahlentherapie und Onkologie, Vol. 175, Issue 10
  • DOI: 10.1007/s000660050059

Radiotherapy and High-Dose Chemotherapy in Advanced Ewing's Tumors
journal, October 1999

  • Pape, Hildegard; Laws, Hans-Jürgen; Burdach, Stefan
  • Strahlentherapie und Onkologie, Vol. 175, Issue 10
  • DOI: 10.1007/s000660050058

T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients
journal, February 1996

  • Riddell, Stanley R.; Elliott, Mark; Lewinsohn, Deborah A.
  • Nature Medicine, Vol. 2, Issue 2
  • DOI: 10.1038/nm0296-216

CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: Implications for cellular immunotherapy of CD20+ malignancy
journal, August 1998


Immunomagnetic Purging of Ewing’s Sarcoma From Blood and Bone Marrow: Quantitation by Real-Time Polymerase Chain Reaction
journal, August 2001

  • Merino, Margret E.; Navid, Fariba; Christensen, Barbara L.
  • Journal of Clinical Oncology, Vol. 19, Issue 16
  • DOI: 10.1200/JCO.2001.19.16.3649

Diganglioside GD2 and Antigen 8H9: Potential Targets for Antibody-Based Immunotherapy against Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
journal, April 1999


Intra-abdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural, and flow cytometric study
journal, August 1993


Expression of HER2/ erb B-2 Correlates With Survival in Osteosarcoma
journal, September 1999

  • Gorlick, Richard; Huvos, Andrew G.; Heller, Glenn
  • Journal of Clinical Oncology, Vol. 17, Issue 9
  • DOI: 10.1200/JCO.1999.17.9.2781

New monoclonal antibodies specific for human sarcomas
journal, July 1986

  • Bruland, Øyvind; Fodstad, Øystein; Funderud, Steinar
  • International Journal of Cancer, Vol. 38, Issue 1
  • DOI: 10.1002/ijc.2910380106

Effect of glycosylation on antibody function: implications for genetic engineering
journal, January 1997


IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
journal, October 1997


High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors
journal, December 1997

  • Chan, Kw; Petropoulos, D.; Choroszy, M.
  • Bone Marrow Transplantation, Vol. 20, Issue 12
  • DOI: 10.1038/sj.bmt.1701014

Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes
journal, January 2001

  • Rossig, Claudia; Bollard, Catherine M.; Nuchtern, Jed G.
  • International Journal of Cancer, Vol. 94, Issue 2
  • DOI: 10.1002/ijc.1457

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
journal, September 1987


Immunocytokines: A Promising Approach to Cancer Immunotherapy
journal, December 1998


Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition
journal, June 1997


Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.
journal, March 1994

  • Celis, E.; Tsai, V.; Crimi, C.
  • Proceedings of the National Academy of Sciences, Vol. 91, Issue 6
  • DOI: 10.1073/pnas.91.6.2105

In Vitro and in Vivo Cytotoxic Activities of Recombinant Immunotoxin 8H9(Fv)-PE38 against Breast Cancer, Osteosarcoma, and Neuroblastoma
journal, February 2004


Man-made antibodies
journal, January 1991

  • Winter, Greg; Milstein, César
  • Nature, Vol. 349, Issue 6307
  • DOI: 10.1038/349293a0

Monoclonal antibody against ependymoma-derived cell line
journal, January 1992

  • Mihara, Yosuke; Matsukado, Yasuhiko; Goto, Satoshi
  • Journal of Neuro-Oncology, Vol. 12, Issue 1
  • DOI: 10.1007/BF00172452

Anti-Idiotypic Antibody Facilitates scFv Chimeric Immune Receptor Gene Transduction and Clonal Expansion of Human Lymphocytes for Tumor Therapy
journal, August 2003


Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin γ1 Fc or CH3 region
journal, July 1999


Reassessment of patient response to monoclonal antibody 3F8.
journal, April 1992


Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors
journal, October 1996

  • Alvarez-Vallina, Luis; Hawkins, Robert E.
  • European Journal of Immunology, Vol. 26, Issue 10
  • DOI: 10.1002/eji.1830261006

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
journal, November 1979

  • Chirgwin, John M.; Przybyla, Alan E.; MacDonald, Raymond J.
  • Biochemistry, Vol. 18, Issue 24
  • DOI: 10.1021/bi00591a005

Characteristics of the cell surface antigen, p72, associated with a variety of human tumours and mitogen-stimulated T-lymphoblasts
journal, June 1984


Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
journal, August 1988

  • Huston, J. S.; Levinson, D.; Mudgett-Hunter, M.
  • Proceedings of the National Academy of Sciences, Vol. 85, Issue 16
  • DOI: 10.1073/pnas.85.16.5879

Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry
journal, January 1993

  • Papanastassiou, V.; Pizer, Bl; Coakham, Hb
  • British Journal of Cancer, Vol. 67, Issue 1
  • DOI: 10.1038/bjc.1993.25

Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma
journal, November 1998


Use of Reverse Transcriptase Polymerase Chain Reaction for Diagnosis and Staging of Alveolar Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors, and Desmoplastic Small Round Cell Tumor
journal, January 2001


In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein
journal, February 1996


Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
journal, January 1993


An alternating selection strategy for cloning phage display antibodies
journal, August 1999


Selection of scFv Phages on Intact Cells Under Low pH Conditions Leads to a Significant Loss of Insert-Free Phages
journal, February 2001

  • Tur, M. K.; Huhn, M.; Sasse, S.
  • BioTechniques, Vol. 30, Issue 2
  • DOI: 10.2144/01302rr04

High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.
journal, August 1995

  • Bunnell, B. A.; Muul, L. M.; Donahue, R. E.
  • Proceedings of the National Academy of Sciences, Vol. 92, Issue 17
  • DOI: 10.1073/pnas.92.17.7739

Biotechnological and gene therapeutic strategies in cancer treatment
journal, June 1995


Comparison of three different methods for radiolabelling human activated T lymphocytes
journal, May 1997

  • Botti, Carlo; Negri, Donatella R. M.; Seregni, Ettore
  • European Journal of Nuclear Medicine, Vol. 24, Issue 5
  • DOI: 10.1007/BF01267680

131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II Study
journal, January 1999


Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes
journal, August 1998

  • Krause, Anja; Guo, Hong-Fen; Latouche, Jean-Baptiste
  • The Journal of Experimental Medicine, Vol. 188, Issue 4
  • DOI: 10.1084/jem.188.4.619

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.
journal, January 1991


Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells
journal, March 1995

  • Holzer, Ursula; Bethge, Wolfgang; Krull, Frauke
  • Cancer Immunology Immunotherapy, Vol. 41, Issue 2
  • DOI: 10.1007/BF01527409

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
journal, January 2002

  • Maher, John; Brentjens, Renier J.; Gunset, Gertrude
  • Nature Biotechnology, Vol. 20, Issue 1
  • DOI: 10.1038/nbt0102-70

Yttrium-90 biodistribution by yttrium-87 imaging: A theoretical feasibility analysis
journal, August 1998


Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
journal, April 1988

  • Cheung, N. K.; Walter, E. I.; Smith-Mensah, W. H.
  • Journal of Clinical Investigation, Vol. 81, Issue 4
  • DOI: 10.1172/JCI113426

Targeting Tumor Specific Translocations in Sarcomas in Pediatric Patients for Immunotherapy
journal, January 2000


Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours
journal, August 1999

  • Fischmeister, G.; Zoubek, A.; Jugovic, D.
  • Bone Marrow Transplantation, Vol. 24, Issue 4
  • DOI: 10.1038/sj.bmt.1701924

Disialoganglioside GD2 anti-idiotypic monoclonal antibodies
journal, May 1993

  • Cheung, Nai-Kong V.; Canete, Adela; Cheung, Irene Y.
  • International Journal of Cancer, Vol. 54, Issue 3
  • DOI: 10.1002/ijc.2910540324

Expression of CD44 splice variants in human primary brain tumors
journal, December 1995

  • Kaaijk, Patricia; Troost, Dirk; Morsink, Folkert
  • Journal of Neuro-Oncology, Vol. 26, Issue 3
  • DOI: 10.1007/BF01052621

In vivo tracking of tumor-specific T cells
journal, April 2001

  • Yee, Cassian; Riddell, Stanley R.; Greenberg, Philip D.
  • Current Opinion in Immunology, Vol. 13, Issue 2, p. 141-146
  • DOI: 10.1016/S0952-7915(00)00196-5

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
journal, August 1970


Physical barriers to drug delivery in tumors
journal, February 1993


Radioimmunolocalisation of human brain tumours: Biodistribution of radiolabelled monoclonal antibody UJ13A
journal, October 1986

  • Richardson, Richard B.; Davies, A. Geraint; Bourne, Stephen P.
  • European Journal of Nuclear Medicine, Vol. 12, Issue 7
  • DOI: 10.1007/BF00263810

Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes.
journal, September 1993

  • Yang, H. Y.; Lieska, N.; Glick, R.
  • Proceedings of the National Academy of Sciences, Vol. 90, Issue 18
  • DOI: 10.1073/pnas.90.18.8534

Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92
journal, August 2001

  • Tonn, Torsten; Becker, Sven; Esser, Ruth
  • Journal of Hematotherapy & Stem Cell Research, Vol. 10, Issue 4
  • DOI: 10.1089/15258160152509145

Radioimmunotherapy: recent results and future directions.
journal, April 1996


Intra-abdominal Desmoplastic Small Round-Cell Tumor: Report of 19 Cases of a Distinctive Type of High-Grade Polyphenotypic Malignancy Affecting Young Individuals
journal, January 1991


Radioimmunotargeting of Human Rhabdomyosarcoma Using Monoclonal Antibody 8H9
journal, October 2005

  • Modak, Shakeel; Guo, Hong Fen; Humm, John L.
  • Cancer Biotherapy and Radiopharmaceuticals, Vol. 20, Issue 5
  • DOI: 10.1089/cbr.2005.20.534

Diagnostic imaging of human neuroblastoma with radiolabeled antibody.
journal, November 1986


Adoptive cellular immunotherapy for EBV lymphoproliferative diseases
journal, June 1997


A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2
journal, May 1991

  • Mujoo, Kalpana; Reisfeld, Ralph A.; Cheung, Lawrence
  • Cancer Immunology Immunotherapy, Vol. 34, Issue 3
  • DOI: 10.1007/BF01742313

Intraparenchymal and Intratumoral Interstitial Infusion of Anti-Glioma Monoclonal Antibody 8h9
journal, December 2008


Functional expression of chimeric receptor genes in human T cells
journal, February 2001


Making Antibodies by Phage Display Technology
journal, April 1994


Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors
journal, February 1999

  • Drengler, Ronald L.; Kuhn, John G.; Schaaf, Larry J.
  • Journal of Clinical Oncology, Vol. 17, Issue 2
  • DOI: 10.1200/JCO.1999.17.2.685

Phage Library-derived Human Anti-TETA and Anti-DOTA ScFv for Pretargeting RIT
journal, February 1999

  • DeNARDO, Sally J.; DeNARDO, Gerald L.; Brush, Jennifer
  • Hybridoma, Vol. 18, Issue 1
  • DOI: 10.1089/hyb.1999.18.13

Cloning of the Human Sodium Iodide Symporter
journal, September 1996

  • Smanik, P. A.; Liu, Q.; Furminger, T. L.
  • Biochemical and Biophysical Research Communications, Vol. 226, Issue 2
  • DOI: 10.1006/bbrc.1996.1358

Intergroup Rhabdomyosarcoma Study: Update for Pathologists
journal, November 1998

  • Qualman, Stephen J.; Coffin, Cheryl M.; Newton, William A.
  • Pediatric and Developmental Pathology, Vol. 1, Issue 6
  • DOI: 10.1007/s100249900076

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.
journal, June 1998

  • Yu, A. L.; Uttenreuther-Fischer, M. M.; Huang, C. S.
  • Journal of Clinical Oncology, Vol. 16, Issue 6
  • DOI: 10.1200/JCO.1998.16.6.2169

Progress in the Diagnosis and Treatment of Rhabdomyosarcoma and Related Soft Tissue Sarcomas
journal, January 2000


Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?
journal, August 1997


Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy
journal, March 2002


Monoclonal antibody against human glioblastoma multiforme (U-87MG) immunoprecipitates a protein of molecular mass 38 kDa and inhibits tumor growth in nude mice
journal, January 1995


Isolation of single chain antibody fragments with specificity for cell surface antigens by phage display utilizing internal image anti-idiotypic antibodies
journal, September 1998


Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers
journal, February 1996


Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
journal, February 1999

  • Umaña, Pablo; Jean–Mairet, Joël; Moudry, Radmila
  • Nature Biotechnology, Vol. 17, Issue 2
  • DOI: 10.1038/6179

Applications of monoclonal antibodies in clinical oncology
journal, December 1994


The Third Intergroup Rhabdomyosarcoma Study.
journal, March 1995


A humanized antibody that binds to the interleukin 2 receptor.
journal, December 1989

  • Queen, C.; Schneider, W. P.; Selick, H. E.
  • Proceedings of the National Academy of Sciences, Vol. 86, Issue 24
  • DOI: 10.1073/pnas.86.24.10029

Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells
journal, November 1997


The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
journal, November 1997

  • Lee, Sean Bong; Kolquist, Kathryn Ann; Nichols, Kim
  • Nature Genetics, Vol. 17, Issue 3
  • DOI: 10.1038/ng1197-309

Occurrence of ganglioside GD3 in neoplastic astrocytes
journal, March 1999

  • Kawai, K.; Takahashi, Hitoshi; Watarai, Shinobu
  • Virchows Archiv, Vol. 434, Issue 3
  • DOI: 10.1007/s004280050328

Production and characterization of human monoclonal anti-idiotype antibodies to anti-dsDNA antibodies
journal, June 2002


Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes
journal, May 1996

  • Heslop, Helen E.; Ng, Catherine Y. C.; Li, Congfen
  • Nature Medicine, Vol. 2, Issue 5
  • DOI: 10.1038/nm0596-551

A new class of antigen-specific killer cells
journal, January 1997

  • Yang, An-Gang; Chen, Si. -Yi
  • Nature Biotechnology, Vol. 15, Issue 1
  • DOI: 10.1038/nbt0197-46

Monoclonal antibody-based therapy for neuroblastoma
journal, December 2000